ON RANDAMISED CLINICAL STUDY OF SIDDHA MEDICINE PERUNGAYA CHOORANAM FOR ACID REFLUX DISEASE
Phase 2
- Conditions
- Health Condition 1: K210- Gastro-esophageal reflux disease with esophagitis
- Registration Number
- CTRI/2022/11/047439
- Lead Sponsor
- MAGUDAPATHI S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Age 18 -60 all gender
2 Epigastric burning
3 Sign of acid reflux
4 Indigestion
5 Abdominal pain
6 Nausea
7 Abdominal bloating
8 H/o NSAID administration
9 FSSG SCALE FOR GERD SCORE
Exclusion Criteria
1 Pregnancy & lactation
2 CA of stomach
3 Barrett esophagus
4 acute pancreatitis
5 Cholelithiasis
6 Pyloric stenosis
7 Gastric perforation
8 H/o Corticosteroid drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of epigastric burning vomiting nausea cough dysphagia abdominal bloating Any one or more of the above results will be considered as primary outcome over the course of 3 or 4 weeks using FSSG GERD SCALETimepoint: The primary outcome will be assessed after a period of 48 days
- Secondary Outcome Measures
Name Time Method The safety and efficacy of the drug will be assessed during the course of the studyTimepoint: The safety and efficacy will be assessed in a time period of 48 days